Core Scientific, Inc.CORZNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank67
3Y CAGR-40.9%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-40.9%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202551.64%
202419.31%
2023-55.34%
2022250.14%
2021295.39%
2020-6.93%
20190.00%